Why Is the Australian Health Sector So Far behind in Practising Climate-Related Disclosures?
Abstract
:1. Introduction
2. Methods
2.1. Methodology and Definition of the Case
2.2. Selection of the Case
2.3. Analysis, Interpretation, and Reporting
3. Results
4. Discussion
4.1. Hypotheses on the Reasons Why the Health Sector Discloses Very Little on Climate Change
4.2. Is There a Similar Pattern in Other Global Markets?
5. Conclusions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Allen, M.R.; Dube, O.P.; Solecki, W.; Aragón-Durand, F.; Cramer, W.; Humphreys, S.; Kainuma, M.; Kala, J.; Mahowald, N.; Mulugetta, Y.; et al. Framing and Context. In Global Warming of 1.5 °C. An IPCC Special Report on the Impacts of Global Warming of 1.5 °C above Pre-Industrial Levels and Related Global Greenhouse Gas Emission Pathways, in the Context of Strengthening the Global Response to the Threat of Climate Change, Sustainable Development, and Efforts to Eradicate Poverty; Masson-Delmotte, V., Zhai, P., Pörtner, H.-O., Roberts, D., Skea, J., Shukla, P.R., Pirani, A., Moufouma-Okia, W., Péan, C., Pidcock, R., et al., Eds.; Cambridge University Press: Cambridge, UK; New York, NY, USA, 2018; pp. 49–92. [Google Scholar] [CrossRef]
- Romanello, M.; McGushin, A.; Di Napoli, C.; Drummond, P.; Hughes, N.; Jamart, L.; Kennard, H.; Lampard, P.; Rodriguez, B.S.; Arnell, N.; et al. The 2021 report of the Lancet Countdown on health and climate change: Code red for a healthy future. Lancet 2021, 398, 1619–1662. [Google Scholar] [CrossRef]
- Watts, N.; Amann, M.; Arnell, N.; Ayeb-Karlsson, S.; Beagley, J.; Belesova, K.; Boykoff, M.; Byass, P.; Cai, W.; Campbell-Lendrum, D.; et al. The 2020 report of the Lancet Countdown on health and climate change: Responding to converging crises. Lancet 2021, 397, 129–170. [Google Scholar] [CrossRef]
- Parry, L.; Radel, C.; Adamo, S.B.; Clark, N.; Counterman, M.; Flores-Yeffal, N.Y.; Pons, D.; Romero-Lankao, P.; Vargo, J. The (in) visible health risks of climate change. Soc. Sci. Med. 2019, 241, 112448. [Google Scholar] [CrossRef] [PubMed]
- IPCC. Climate Change 2022: Impacts, Adaptation, and Vulnerability. Contribution of Working Group II to the Sixth Assessment Report of the Intergovernmental Panel on Climate Change; Pörtner, H.-O., Roberts, D.C., Tignor, M., Poloczanska, E.S., Mintenbeck, K., Alegría, A., Craig, M., Langsdorf, S., Löschke, S., Möller, V., et al., Eds.; Cambridge University Press: Cambridge UK; New York, NY, USA, 2022; in press. [Google Scholar]
- Dahl, T.; Fløttum, K. Climate change as a corporate strategy issue: A discourse analysis of three climate reports from the energy sector. Corp. Commun. 2019, 24, 499–514. [Google Scholar] [CrossRef]
- Choi, B.; Lee, B.; Psaros, J. An analysis of Australian company carbon emission disclosures. Pac. Account. Rev. 2013, 25, 58–79. [Google Scholar] [CrossRef]
- Amran, A.; Periasamy, V.; Zulkafli, A.H. Determinants of Climate Change Disclosure by Developed and Emerging Countries in Asia Pacific. Sustain. Dev. 2014, 22, 188–204. [Google Scholar] [CrossRef]
- Efimova, O.; Rozhnova, O.; Zvyagintseva, E. Creation of a System for Climate-Related Risks Disclosures in Companies. Integrated Science in Digital Age 2020. 2021. Available online: https://link.springer.com/chapter/10.1007/978-3-030-49264-9_18 (accessed on 12 August 2022).
- De Grosbois, D.; Fennell, D.A. Determinants of climate change disclosure practices of global hotel companies: Application of institutional and stakeholder theories. Tour. Manag. 2021, 88, 104404. [Google Scholar] [CrossRef]
- Jiang, Y.; Luo, L.; Xu, J.; Shao, X. The value relevance of corporate voluntary carbon disclosure: Evidence from the United States and BRIC countries. J. Contemp. Account. Econ. 2021, 17, 100279. [Google Scholar] [CrossRef]
- Hahn, R.; Reimsbach, D.; Schiemann, F. Organizations, climate change, and transparency: Reviewing the literature on carbon disclosure. Organ. Environ. 2015, 28, 80–102. [Google Scholar] [CrossRef]
- Bolton, P.; Reichelstein, S.; Kacperczyk, M.T.; Leuz, C.; Ormazabal, G.; Schoenmaker, D. Mandatory Corporate Carbon Disclosures and the Path to Net Zero. Manag. Bus. Rev. 2021, 1. Available online: https://ssrn.com/abstract=4059588 (accessed on 12 August 2022). [CrossRef]
- Carbon Disclosure Project. Guidance for Companies. 2022. Available online: https://www.cdp.net/en/guidance/guidance-for-companies (accessed on 8 August 2022).
- EY. Climate Risk Disclosure Barometer: Australia 2019. In Are You Prepared for the Increasing Investor Scrutiny on Climate Risk Disclosures? Ernst & Young ABC Pty Limited: Melbourne, VIC, Australia, 2019. [Google Scholar]
- Malik, A.; Lenzen, M.; McAlister, S.; McGain, F. The carbon footprint of Australian health care. Lancet Planet. Health 2018, 2, e27–e35. [Google Scholar] [CrossRef] [Green Version]
- Foerster, A.; Peel, J.; Osofsky, H.M.; McDonnell, B. Keeping Good Company in the Transition to a Low Carbon Economy? An Evaluation of Climate Risk Disclosure Practices in Australia. Co. Secur. Law J. 2017, 35, 154–183. [Google Scholar]
- Ali, W.; Frynas, J.G.; Mahmood, Z. Determinants of corporate social responsibility (CSR) disclosure in developed and developing countries: A literature review. Corp. Soc. Responsib. Environ. Manag. 2017, 24, 273–294. [Google Scholar] [CrossRef]
- Papas, M. The 2030 Sustainable Development Agenda and the Paris Climate Agreement—taking urgent action to combat climate change: How is Australia likely to fare? Asia Pac. J. Environ. Law 2017, 20, 94–114. [Google Scholar] [CrossRef]
- Brolan, C.E.; Hall, N.; Creamer, S.; Johnston, I.; Dantas, J.A. Health’s role in achieving Australia’s Sustainable Development Goal commitments. Med. J. Aust. 2019, 210, 204–206.e1. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zumente, I.; Lāce, N. ESG Rating—Necessity for the Investor or the Company? Sustainability 2021, 13, 8940. [Google Scholar] [CrossRef]
- Halbritter, G.; Dorfleitner, G. The wages of social responsibility—Where are they? A critical review of ESG investing. Rev. Financ. Econ. 2015, 26, 25–35. [Google Scholar] [CrossRef]
- Ángel Del Brío, J.; Lizarzaburu Bolaños, E. CSR Actions in companies and perception of their reputation by managers: Analysis in the rural area of an emerging country in the banking sector. Sustainability 2018, 10, 920. [Google Scholar] [CrossRef] [Green Version]
- Belkhir, L.; Elmeligi, A. Carbon footprint of the global pharmaceutical industry and relative impact of its major players. J. Clean. Prod. 2019, 214, 185–194. [Google Scholar] [CrossRef]
- Santamaria, R.; Paolone, F.; Cucari, N.; Dezi, L. Non-financial strategy disclosure and environmental, social and governance score: Insight from a configurational approach. Bus. Strategy Environ. 2021, 30, 1993–2007. [Google Scholar] [CrossRef]
- Ciriminna, R.; Pagliaro, M. Green chemistry in the fine chemicals and pharmaceutical industries. Org. Process Res. Dev. 2013, 17, 1479–1484. [Google Scholar] [CrossRef]
- Hensher, M.; McGain, F. Health Care Sustainability Metrics: Building A Safer, Low-Carbon Health System: Commentary examines how to build a safer, low-carbon health system. Health Aff. 2020, 39, 2080–2087. [Google Scholar] [CrossRef] [PubMed]
- Morisson, L. Changing the Climate on Corporate Emissions; Final Report; CPA Australia Global Research Perspectives Program; RMIT University: Melbourne, Australia, 2021. [Google Scholar]
- Kumar, A.; Zavadskas, E.K.; Mangla, S.K.; Agrawal, V.; Sharma, K.; Gupta, D. When risks need attention: Adoption of green supply chain initiatives in the pharmaceutical industry. Int. J. Prod. Res. 2019, 57, 3554–3576. [Google Scholar] [CrossRef]
- Crowe, S.; Cresswell, K.; Robertson, A.; Huby, G.; Avery, A.; Sheikh, A. The case study approach. BMC Med. Res. Methodol. 2011, 11, 100. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dumay, J.; Hossain, M.A. Sustainability risk disclosure practices of listed companies in Australia. Aust. Account. Rev. 2019, 29, 343–359. [Google Scholar] [CrossRef]
- Eccles, R.G.; Krzus, M.P. Why companies should report financial risks from climate change. MIT Sloan Manag. Rev. 2018, 59, 1–6. [Google Scholar]
- Association of Chartered Certified Accountants. Disclosures on Supply Chain Sustainability; A Joint Report from ACCA, the Net Balance Foundation and the Sustainable Investment Research Institute; ACCA: London, UK, 2011. [Google Scholar]
- Ben-Amar, W.; Chang, M.; McIlkenny, P. Board gender diversity and corporate response to sustainability initiatives: Evidence from the carbon disclosure project. J. Bus. Ethics 2017, 142, 369–383. [Google Scholar] [CrossRef] [Green Version]
- Carbon Disclosure Project. ANSELL—Climate Change 2021. 2021. Available online: https://www.cdp.net/en/formatted_responses/responses?campaign_id=74241094&discloser_id=896524&locale=en&organization_name=Ansell&organization_number=806&program=Investor&project_year=2021&redirect=https%3A%2F%2Fcdp.credit360.com%2Fsurveys%2F2021%2Fdbbr64mv%2F147030&survey_id=73557641 (accessed on 5 August 2022).
- Carbon Disclosure Project. CSL—Climate Change 2021. 2021. Available online: https://www.cdp.net/en/formatted_responses/responses?campaign_id=74241094&discloser_id=897168&locale=en&organization_name=CSL&organization_number=4052&program=Investor&project_year=2021&redirect=https%3A%2F%2Fcdp.credit360.com%2Fsurveys%2F2021%2Fdbbr64mv%2F141342&survey_id=73557641 (accessed on 5 August 2022).
- Hertwich, E.G.; Wood, R. The growing importance of scope 3 greenhouse gas emissions from industry. Environ. Res. Lett. 2018, 13, 104013. [Google Scholar] [CrossRef]
- Downie, J.; Stubbs, W. Evaluation of Australian companies’ scope 3 greenhouse gas emissions assessments. J. Clean. Prod. 2013, 56, 156–163. [Google Scholar] [CrossRef]
- Ducoulombier, F. Understanding the importance of scope 3 emissions and the implications of data limitations. J. Impact ESG Investig. 2021, 1, 63–71. [Google Scholar] [CrossRef]
- Stechemesser, K.; Guenther, E. Carbon accounting: A systematic literature review. J. Clean. Prod. 2012, 36, 17–38. [Google Scholar] [CrossRef]
- He, R.; Luo, L.; Shamsuddin, A.; Tang, Q. Corporate carbon accounting: A literature review of carbon accounting research from the Kyoto Protocol to the Paris Agreement. Account. Financ. 2022, 62, 261–298. [Google Scholar] [CrossRef]
- Task Force on Climate-Related Financial Disclosures. Recommendations of the Task Force on Climate-Related Financial Disclosures; Task Force on Climate-Related Financial Disclosures: New york, NY, USA, 2017. [Google Scholar]
- Global Programme on Risk Assessment and Management for Adaptation to Climate Change. Assessment of Climate-Related Risks, A 6-Step Methodology; Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH: Bonn, Germany, 2021. [Google Scholar]
- Hsu GC, M.; Clarkson, P.; Ouyang, A.X. Do biotechnology and health-care firms have poorer continuous disclosure practices as reflected in ASX queries? Account. Res. J. 2019, 32, 88–112. [Google Scholar] [CrossRef]
- Sanderson, H.; Irato, D.M.; Cerezo, N.P.; Duel, H.; Faria, P.; Torres, E.F. How do climate risks affect corporations and how could they address these risks? SN Appl. Sci. 2019, 1, 1720. [Google Scholar] [CrossRef] [Green Version]
- Battiston, S.; Dafermos, Y.; Monasterolo, I. Climate risks and financial stability. J. Financ. Stab. 2021, 54, 100867. [Google Scholar] [CrossRef]
- The Department of Homeland Security. The Public-Private Analytic Exchange Program. Threats to Pharmaceutical Supply Chains; 2018. Available online: https://www.dhs.gov/publication/dhsiapia-001-public-private-sector-analytic-exchange-program-aep (accessed on 18 September 2022).
- Ambrosio Preudhomme, N.; Mazzacurati, E. Asset-Level Physical Climate Risk Disclosure. In Values at Work; Palgrave Macmillan: Cham, Switzerland, 2020; pp. 67–80. [Google Scholar]
- Chaturvedi, U.; Sharma, M.; Dangayach, G.S.; Sarkar, P. Evolution and adoption of sustainable practices in the pharmaceutical industry: An overview with an Indian perspective. J. Clean. Prod. 2017, 168, 1358–1369. [Google Scholar] [CrossRef]
- Salt, J.E. Health and climate change: Implications for the pharmaceutical sector. In Annual Reports in Medicinal Chemistry; Elsevier: Amsterdam, The Netherlands, 2003. [Google Scholar]
- Redshaw, C.H.; Stahl-Timmins, W.M.; Fleming, L.E.; Davidson, I.; Depledge, M.H. Potential changes in disease patterns and pharmaceutical use in response to climate change. J. Toxicol. Environ. Health Part B 2013, 16, 285–320. [Google Scholar] [CrossRef] [Green Version]
- Garcia, L.C.; Beverley, M. Reinvigorating Puerto Rico’s Pharmaceutical Industry: A US Security Imperative. Cent. J. 2021, 33, 56–93. [Google Scholar]
- Khan, I.; Shah, S.M. Hazards in Pharmaceutical Industry. In Essentials of Industrial Pharmacy; Springer: Cham, Switzerland, 2022; pp. 203–216. [Google Scholar]
- Fink, L.; A Fundamental Reshaping of Finance. Blackrock. January 2020. Available online: https://www.blackrock.com/corporate/investor-relations/larry-fink-ceo-letter (accessed on 15 September 2022).
- Das, S.; Jeni, F.A. Climate Change Disclosure Performance of Pharmaceutical Industry of Bangladesh. Asian J. Bus. Environ. 2021, 11, 39–45. [Google Scholar] [CrossRef]
- Kumar, M.; Mohanty, B.; Narayan, M.; Vadera, M.L. Sustainability Reporting Pattern in Pharmaceutical Sector: A Study of Top 10 Economies across the Globe. Int. J. Res. Pharm. Sci. 2020, 11, 460–465. [Google Scholar] [CrossRef]
- Enyinda, C.I.; Mbah, C.H.N.; Ogbuehi, A. An empirical analysis of risk mitigation in the pharmaceutical industry supply chain: A developing-country perspective. Thunderbird Int. Bus. Rev. 2010, 52, 45–54. [Google Scholar] [CrossRef]
- Bassen, A.; Busch, T.; Lopatta, K.; Evans, E.; Opoku, O.; Nature Risks Equal Financial RISKS: A Systematic Literature Review. Universität Hamburg, Verfügbar Unter 2019. Available online: https://www.wwf.ch/sites/default/files/doc-2019-11/Nature_Risks_equal_Financial_Risks_RG_Sustainable_Finance_Hamburg_2019_final.pdf (accessed on 15 September 2022).
- Ameli, N.; Drummond, P.; Bisaro, A.; Grubb, M.; Chenet, H. Climate finance and disclosure for institutional investors: Why transparency is not enough. Clim. Chang. 2020, 160, 565–589. [Google Scholar] [CrossRef]
- Lee, S.Y.; Park, Y.S.; Klassen, R.D. Market responses to firms’ voluntary climate change information disclosure and carbon communication. Corp. Soc. Responsib. Environ. Manag. 2015, 22, 1–12. [Google Scholar] [CrossRef]
- O’Dwyer, B.; Unerman, J. Shifting the focus of sustainability accounting from impacts to risks and dependencies: Researching the transformative potential of TCFD reporting. Account. Audit. Account. J. 2020, 33, 1113–1141. [Google Scholar] [CrossRef]
- Andrew, J.; Cortese, C. Accounting for climate change and the self-regulation of carbon disclosures. Account. Forum 2011, 35, 130–138. [Google Scholar] [CrossRef]
- Giannarakis, G.; Zafeiriou, E.; Sariannidis, N. The Impact of Carbon Performance on Climate Change Disclosure. Bus. Strat. Environ. 2017, 26, 1078–1094. [Google Scholar] [CrossRef]
- Patz, J.A.; Frumkin, H.; Holloway, T.; Vimont, D.J.; Haines, A. Climate change: Challenges and opportunities for global health. JAMA 2014, 312, 1565–1580. [Google Scholar] [CrossRef]
- Boettke, P.; Powell, B. The political economy of the COVID-19 pandemic. South. Econ. J. 2021, 87, 1090–1106. [Google Scholar] [CrossRef]
- Gruenberg, K.; Apollonio, D.; MacDougall, C.; Brock, T. Sustainable Pharmacy: Piloting a Session on Pharmaceuticals, Climate Change, and Sustainability within a U.S. Pharmacy Curriculum. Innov. Pharm. 2017, 8, 3. [Google Scholar] [CrossRef] [Green Version]
- Mason, A.N.; Elkassabgi, A. Evidence of Abnormal Trading on COVID-19 Pfizer Vaccine Development Information. J. Risk Financ. Manag. 2022, 15, 299. [Google Scholar] [CrossRef]
- Orsenigo, L.; Sterzi, V. Comparative Study of the Use of Patents in Different Industries. In KITeS, Centre for Knowledge, Internationalization and Technology Studies, KITeS Working Papers 033; Universita’ Commerciale Luigi Bocconi: Milano, Italy, 2010; pp. 1–31. [Google Scholar]
- Pak, A.; Adegboye, O.A.; Adekunle, A.I.; Rahman, K.M.; McBryde, E.S.; Eisen, D.P. Economic consequences of the COVID-19 outbreak: The need for epidemic preparedness. Front. Public Health 2020, 8, 241. [Google Scholar] [CrossRef] [PubMed]
- Jennings, K. Forbes Global 2000: The World’s Largest Healthcare Companies in 2022; Forbes: Jersey City, NY, USA, 2022. [Google Scholar]
Company | ANSELL | Coachlear | CSL | Ramsay Health Care | Resmed Inc. | Sonic Healthcare |
---|---|---|---|---|---|---|
Disclosures | ||||||
Climate Change 2021 | Submitted B | Submitted Not Available | Submitted D | No Response | No Response | No Response |
Climate Change 2020 | Submitted B | No Response | Submitted C | No Response | No Response | No Response |
Climate Change 2019 | Submitted B | No Response | Submitted C | No Response | No Response | No Response |
Climate Change 2018 | Submitted C | No Response | Submitted D | No Response | Declined to Participate | No Response |
SECTORS | Weight in the S&P/ASX100 (In %) | Environmental Performance Based on Climate Change Disclosures (In %) | Ratio between Weight and Environmental Performance per Sector | Ratio Ranking |
---|---|---|---|---|
FINANCIALS | 30.54 | 19.10 | 0.625 | 8 |
MATERIALS | 17.77 | 14.60 | 0.821 | 7 |
HEALTHCARE | 10.33 | 3.55 | 0.344 | 9 |
INDUSTRIALS | 8.45 | 12.00 | 1.420 | 6 |
REAL ESTATE | 6.90 | 27.35 | 3.964 | 3 |
TELECOMMUNICATIONS AND IT | 6.27 | 37.50 | 5.981 | 1 |
CONSUMER DISCRETIONARY | 6.13 | 7.65 | 1.248 | |
ENERGY | 6.08 | 16.75 | 2.755 | 5 |
CONSUMER STAPLES | 5.50 | 31.25 | 5.682 | 2 |
UTILITIES | 2.07 | 7.90 | 3.816 | 4 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Deweerdt, T. Why Is the Australian Health Sector So Far behind in Practising Climate-Related Disclosures? Int. J. Environ. Res. Public Health 2022, 19, 12822. https://doi.org/10.3390/ijerph191912822
Deweerdt T. Why Is the Australian Health Sector So Far behind in Practising Climate-Related Disclosures? International Journal of Environmental Research and Public Health. 2022; 19(19):12822. https://doi.org/10.3390/ijerph191912822
Chicago/Turabian StyleDeweerdt, Tom. 2022. "Why Is the Australian Health Sector So Far behind in Practising Climate-Related Disclosures?" International Journal of Environmental Research and Public Health 19, no. 19: 12822. https://doi.org/10.3390/ijerph191912822